Multi-locus sequence analysis for identification of Achromobacter xylosoxidans from blood culture

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Infectious Diseases

• Publication date

  2016-07-04

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1080/23744235.2016.1203987PMID 27376508
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Distribution of the species of Achromobacter in a French Cystic Fibrosis Centre and multilocus sequence typing analysis reveal the predominance of A. xylosoxidans and clonal relationships between some clinical and environmental isolates.

  2016cited by this paper
• Inter- and intra-individual variations in seasonal and daily stabilities of the human gut microbiota in Japanese

  2015cited by this paper
• Development of a Prokaryotic Universal Primer for Simultaneous Analysis of Bacteria and Archaea Using Next-Generation Sequencing

  2014cited by this paper
• Genotypic and Phenotypic Applications for the Differentiation and Species-Level Identification of Achromobacter for Clinical Diagnoses

  2014cited by this paper
• Skin and soft tissue infection caused by Achromobacter xylosoxidans: report of 14 cases

  2014cited by this paper
• A Multilocus Sequence Typing Scheme Implies Population Structure and Reveals Several Putative Novel Achromobacter Species

  2012cited by this paper
• Multilocus Sequence Analysis of Isolates of Achromobacter from Patients with Cystic Fibrosis Reveals Infecting Species Other than Achromobacter xylosoxidans

  2012cited by this paper
• Bacteremia caused by Achromobacter and Alcaligenes species in 46 patients with cancer (1989–2003)

  2004cited by this paper
• Achromobacter xylosoxidans Bacteremia: A 10-Year Analysis of 54 Cases

  2003cited by this paper
• Achromobacter xylosoxidans bacteremia: report of four cases and review of the literature.

  1996cited by this paper

• Molecular diagnosis of sepsis in hospital patients: assessment of the Agata Sepsis® Platform.

  2026cites this paper